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There can be two phases identi f ied in the natural history of asthma: the
development  of  asthma and the progress ion of  asthma.  The outcome of  ch i ldhood
asthma is  genera l ly  thought  o be a good one.  However,  s tudies have shown that
asthma patients may end up with either severe disease or without disease. These
disease states represent the extremes of the disease, i .e. irreversible ainruay
obstruction accompanied by an accelerated ecl ine in FEVI áS €r result of airway
remodel l ing,  and complete remiss ion in  adul thood wi thout  symptoms or 'need for
asthma t reatment ,  a normal  ung funct ion and absence of  bronchia l
hyperresponsiveness (BHR). In this thesis these aspects of the natural history of
asthma are being described and early l i fe factors associated with either a benign or
a poor outcome have been identi f ied.
Ghapter 1 gives an introduction on the subject. An increasing number of people is
developing asthma compared to the number 30 years agol -3.  This  r ise in  prevalence
in recent decades is especial ly high in the more aff luent countr ies. Recent research
has indicated that factors such as exposure to other chi ldrena-6 or l iving on a farm
dur ing the f i rs t  years of  l i feT-10 protect  against  the development  of  asthma.  This
f ind ing made sc ient is ts  focus on the developing immune system to expla in the r ise
in asthma prevalence.  The current  opin ion is  that  young chi ldren and toddlers in  the
Western society are less exposed in recent decades to factors that induce a Thr
response from the immune system. This then gives way to the development of aThz
response,  which is  involved in  lgE mediated a l lergy.  This  decrease in  exposure is
thought  o resul t  f rom higher  hygienic  s tandards and a reduced s ize of  fami l ies wi th
less cross-infection between sibl ingss. Recent studies have indicated that there
certainly is evidence in favour of this so-cal led hygiene-hypothesis, but other factors
such as family history and pre- and perinatal factors, are also important. In the
l i terature on r isk factors for the development of asthma, there is a lack of long-term
studies that simultaneously take into account perinatal factors, genetic
predisposit ion, and r isk factors later in l i fe such as smoking habits.
Af ter  the d iagnosis  of  asthma is  made in  an ind iv idual  i t is  important  to  know the
prognosis of the disease. l t  is of great priori ty to determine prognostic factors in
chi ldhood asthma since this can lead to more effect ive and eff icient treatment
regimens.  Severa l  s tudies have shown that  the sever i ty  of  the d isease in  ch i ldhood,
as assessed by presence or severity of symptoms, level of lung function or BHR, is
a very important  predic tor  for  the sever i ty  of  the d isease in  adul thoodl l -18.  The
li terature concerning early predict ive factors for the prognosis of asthma has mainly
focused on identi f icat ion of predict ive factors for a symptomatic state of asthma and
for the use of anti- inf lammatory medication after a certain length of fol low-up, Long-
term studies on early predict ive factors associated with the natural course of other
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Summary, discussion, and future perspectives
The development ofasthma in a prospective cohort of all newborn babies born
between 1975 and 1978 in the Department ofObstetrics of the University Hospital in
Groningen, The Netherlandstn, is the subject of chapters 2 and 3 of this thesis. The
uniqueness of these studies lies in the long period of follow-up (20 years) and the
availability ofdetailed information on child delivery and other perinatal factors. This
offered us the possibility o investigate heir association with respiratory morbidity at
a young adult age, while at the same time adjusting for smoking habits and familial
predisposit ion.
ln Chapter 2 risk factors for symptom development and level of lung function at a
young adult age were investigated. At follow-up 39oÁ of the 1568 responders
reported at least one respiratory symptom. Females reported symptoms more often
than males. Taking other potential risk factors into account, being first-born was
associated with a reduced risk of asthmatic symptoms (wheeze or nocturnal
dyspnoea) and with a higher achieved level of lung function. Having had a mother
who smoked during pregnancy and having a low birth weight were independently
associated with a lower level oÍ lung function but not with the development of
symptoms. Having had a severe respiratory tract infection in the first year of life was
associated with both the development ofasthmatic symptoms and a lower achieved
level of lung function at a young adult age. Other investigated perinatal factors (i.e.
gestational ge, maternal age, method of feeding, and environmental tobacco
smoke exposure) were not associated with the development of symptoms or the
achieved level of lung function.
Predictive factors for the development ofatopy and BHR were identified in Chapter
3. Apart from the risk factors described in chapter 2, factors related to the delivery of
the child were also investigated, such as mode of delivery (use of vacuum pump,
forceps, or a caesarean section), duration of delivery, induction of labour with
medication, and position of the foetus. Twenty-five percent of this large birth cohort
had BHR and almost 50% had atopy after a follow-up of 20 years. A delivery-
duration longer than 12 hours was associated with the development ofatopy and
having had a severe respiratory infection in the first year of life was associated with
the development of BHR. In the non-atopic subjects, being born by induced labour
and current smoking were risk factors for the presence of BHR. Finally, having been
exposed to smoke prenatally and to pets in childhood were associated with a
decreased risk for the development ofatopy, especially in BHR-positive subjects.
There was no association between the development of BHR or atopy and having
been breastfed for at least 2 weeks, having a parent with asthma or allergy, being
first born, mode of delivery, position of the foetus during delivery, and birth weight.
Chapters 4 to 7 concern the prognosis of asthma: in chapters 4 and 5 risk factors for
worsening of asthma have been described and in chapters 6 and 7 we identiÍied
factors that are predictive of remission of the disease in adulthood.
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Chapter B
Although asthma is general ly bel ieved to be a benign disease with ful ly reversible
ainruay obstruction, i t has recently been acknowledged that a subgroup of patients
develops persistent and progressive ainvay obstruction, probably as a result of
airway remodeling. The results of the fol low-up study with a duration of 26 years,
presented in Ghapter 4, indicated that the development of irreversible airway
obstruction in adulthood (age 35-74) was associated with a lower FEVr, less
reversibi l i ty of ainruay obstruction, and, surprisingly, with less severe BHR at ini t ial
test ing. The use of anti- inf lammatory medication did not result in less airuuay
obstruction but prevented the development of irreversibi l i ty. Furthermore, addit ional
analyses suggested that the longer the period between the onset of symptoms and
the start of treatment he higher the r isk of developing irreversible ainruay
obstruction. Another outcome measure investigated in this chapter was a reduced
transfer factor (Kco), a marker that is highly correlated with the presence of
emphysema. Having smoked more pack years and being female were independent
risk factors for the presence of a reduced Kco. lt was concluded that although a
reduced Kco and irreversibility are both characteristics of chronic obstructive
pulmonary disease, they represent two dist inct groups with regard to
symptomatology, aetiology, and treatment approach in this populat ion of patients
with asthma.
ln Chapter 5 the annual decl ine of lung function after age 30 in this same cohort
was investigated. Only in males who had smoked less than 5 pack years at fol low-
up did the use of inhaled cort icosteroids result in a reduction of the annual lung
function decl ine. This may suggest a dif ferent effect of anti- inf lammatory medication
in men and women and clearly needs further study. Less severe BHR at ini t ial
test ing and the presence of dyspnoea or wheezing at fol low-up were associated with
a more accelerated annual decl ine in lung function in females. The presence of
sputum production at fol low-up was associated with a more accelerated ecl ine in
both sexes. This accelerated lung function decl ine in the presence of respiratory
symptoms possibly indicates undertreatment.
Remission of asthma in adulthood is usually defined as absence of symptoms and
no medication use. In chapter 6 and 7 more r igorous definit ions of asthma remission
were used and early factors associated with remission of asthma were identi f ied.
Ghapter 6 describes remission of asthma in the same cohort as used in chapter 4
and 5 to assess a negative outcome of asthma. When remission of asthma was
defined as no BHR, FEVr > 90% predicted, and the absence of pulmonary
symptoms reported by the patient, only 20 subjects (11%) were no longer
considered asthmatic when retested after 25 year, while 40% was symptom-free,
21o/o no longer showed BHR, and 25% had an FEVI > 90% predicted. The
normal izat ion lung funct ion,  as wel l  as remiss ion of  BHR and asthma was
associated with a younger age and less severe airway obstruction at f i rst test ing. A
shorter period between the onset of symptoms and the start of special ized treatment
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treatment of asthma may have prevented persistence of the disease, even in
adolescents and adults 13 to 44 years of age.
In Ghapter 7 factors associated with both ful l  and cl inical remission of asthma were
identi f ied in a cohort of asthma patients aged 5 to 14 years at ini t ial  examination.
Ful l  remission of asthma at fol low-up was defined as: no asthma symptoms, no use
of inhaled cort icosteroids, normal lung function (FEV1 > 90% predicted), and no
BHR (PCro > '16 mg/ml) .  Cl in ica l  remiss ion was def ined as no asthma symptoms
and no use of inhaled cort icosteroids. After a fol low-up eriod of 30 years (age 32 to
42 years) 22% was in ful l  remission of asthma and 52o/o was in cl inical remission.
Fif ty-seven percent of subjects in cl inical remission had BHR and/or a low lung
function. Both ful l  and cl inical remission were associated with a higher lung function
level  in  ch i ldhood and more improvement  in  FEVr f rom age 5-14to21-33.
Discussion
Epidemiological and SÍaÍistical aspects
All  studies reported in this thesis are prospective cohort studies. In this classic
epidemiological study design a group of subjects (a cohort) is selected from the
populat ion and basel ine measurements are being made.  Subsequent ly  th is  cohor t  is
fol lowed-up over a certain period of t ime and one or more re-examinations are
performed. Advantages of this study design are the str ict control over the sample-
selection and the prospective nature of the data col lect ion that makes i t  possible to
describe a time sequence between potential risk factors and health effects.
Moreover, since chi ldhood factors are measured prospectively the phenomenon of
recal l  bias is not present. Disadvantages are the high costs involved and the r isk of
a relat ively high loss-to-fol low-up-rate. Another disadvantage is the possibi l i ty that
dur ing the course of  the study the prevai l ing ideas about  d isease development  and
progression may change, leading to a focus on other chi ldhood prospective r isk
factors that were not measured.
In al l  studies, except for the study on lung function decl ine in chapter 5, only one
(chapter 2,3, 4, and 6) or two (chapter 7) fol low-up measurements were performed
after the init ial  measurements that establ ished the subject 's membership of the
cohort.  Given this restr icted number of measurements per subjects basic
mult ivariable regression techniques were used to identi fy predict ive factors from the
init ial  measurement for the outcome parameter measured during fol low-up. The
predictors oÍ interest were entered in a l inear or logist ic regression model while
adjustment for possible confounders was performed as well .  Interactions between
the predictive factors were investigated and the associations were checked for non-
l inearity. In chapter 3 a special type of logist ic regression was used, i .e. mult inomial
logist ic regression. In this type of regression analysis the outcome parameter
consists of more than two categories and r isk estimates are calculated for each
outcome category compared to the reference category. An alternative to this would
be to strat i fy the analysis, e.g. perform a regression analysis on BHR-development
99
